REVELATION BIOSCIENCES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
REVELATION BIOSCIENCES, INC. (REVB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- REVELATION BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.60M, a 40.91% decline from fiscal 2024.
- REVELATION BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.40M, a 119.57% increase from fiscal 2023.
- REVELATION BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $2.00M, a 50.06% decline from fiscal 2022.
- REVELATION BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $4.01M, a 20.75% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.60M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $4.40M 10-K · filed 2026-02-26 | $4.42M 10-K · filed 2025-03-06 |
| 2023-12-31 | $2.00M 10-K · filed 2025-03-06 | |
| 2022-12-31 | $4.01M 10-K/A · filed 2024-09-23 | |
| 2021-12-31 | $3.32M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |